Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis
Top Cited Papers
- 8 October 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Protocols
- Vol. 4 (11), 1565-1573
- https://doi.org/10.1038/nprot.2009.187
Abstract
The mouse model of oxygen-induced retinopathy (OIR) has been widely used in studies related to retinopathy of prematurity, proliferative diabetic retinopathy and in studies evaluating the efficacy of antiangiogenic compounds. In this model, 7-d-old (P7) mouse pups with nursing mothers are subjected to hyperoxia (75% oxygen) for 5 d, which inhibits retinal vessel growth and causes significant vessel loss. On P12, mice are returned to room air and the hypoxic avascular retina triggers both normal vessel regrowth and retinal neovascularization (NV), which is maximal at P17. Neovascularization spontaneously regresses between P17 and P25. Although the OIR model has been the cornerstone of studies investigating proliferative retinopathies, there is currently no harmonized protocol to assess aspects of angiogenesis and treatment outcome. In this protocol we describe standards for mouse size, sample size, retinal preparation, quantification of vascular loss, vascular regrowth, NV and neovascular regression.Keywords
This publication has 31 references indexed in Scilit:
- Suppression of Retinal Neovascularization by Erythropoietin siRNA in a Mouse Model of Proliferative RetinopathyInvestigative Ophthalmology & Visual Science, 2009
- A mechanosensitive transcriptional mechanism that controls angiogenesisNature, 2009
- MCP-1 Deficiency Delays Regression of Pathologic Retinal Neovascularization in a Model of Ischemic RetinopathyInvestigative Ophthalmology & Visual Science, 2008
- Leukemia inhibitory factor regulates microvessel density by modulating oxygen-dependent VEGF expression in miceJCI Insight, 2008
- Erythropoietin deficiency decreases vascular stability in miceJCI Insight, 2008
- IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowthProceedings of the National Academy of Sciences of the United States of America, 2007
- Neurogenesis, Angiogenesis, and MRI Indices of Functional Recovery From StrokeStroke, 2007
- Combination angiostatic therapy completely inhibits ocular and tumor angiogenesisProceedings of the National Academy of Sciences of the United States of America, 2007
- Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathyJCI Insight, 2006
- Differential expression of pro- and antiangiogenic factors in mouse strain-dependent hypoxia-induced retinal neovascularizationLaboratory Investigation, 2005